| NCT ID | NCT06512168 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Central Florida |
| Condition | Down Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2028-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-04-01 with a primary completion date of 2028-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The focus of the current study is to systematically investigate the psychometric properties of a range of aided language measures, which are based on the Graphic Symbol Utterance and Sentence Development Framework (Binger \& Kent-Walsh).
Eligibility Criteria
Inclusion Criteria: * Clinical Identification of Down Syndrome or Cerebral Palsy + Significant Speech Impairment * Must Speak English as a Primary Language * Must Be Able to Express At Least 25 Words (using any communication mode) * Must Be Able to Accurately Select Picture Symbols on iPad Communication App with at Least 50% Accuracy * Vision and Hearing within Functional Limits or Corrected to be within Functional Limits for Study Activities Exclusion Criteria: * Clinical Diagnosis of Autism or Social Communication Disorder * Primary Language Spoken is A Language Other than English
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06512168 clinical trial?
This trial is open to participants of all sexes, aged 42 Months or older, up to 60 Months, studying Down Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06512168 currently recruiting?
Yes, NCT06512168 is actively recruiting participants. Contact the research team at Jkentwalsh@ucf.edu for enrollment information.
Where is the NCT06512168 trial being conducted?
This trial is being conducted at Orlando, United States.
Who is sponsoring the NCT06512168 clinical trial?
NCT06512168 is sponsored by University of Central Florida. The trial plans to enroll 60 participants.